Home > Insider Trading > Filing (0001179110-19-008066)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1597264	Blueprint Medicines Corp	BPMC	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1383292	Jr A Charles Rowland	C/O Blueprint Medicines Corporation 45 Sidney Street Cambridge MA 02139		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2019-06-20	11,818	$9.46	11,818	No	4	M	Direct
Common Stock	Disposition	2019-06-20	947	$96.69	10,871	No	4	S	Direct
Common Stock	Disposition	2019-06-20	1,600	$96.08	9,271	No	4	S	Direct
Common Stock	Disposition	2019-06-20	9,271	$94.83	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2019-06-20	11,818	$0.00	11,818	$9.46

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
10,000		2025-03-22	No	4	M	Direct

Footnotes

The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.29 to $97.25 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) through (3) of this Form 4.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.00 to $96.25 per share.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.63 to $94.89 per share.
This option was granted on March 22, 2015. This option vested with respect to 1/36th of the shares underlying the option on April 16, 2015 and vested as to an additional 1/36th of the shares underlying the option each month thereafter.